Skip to main content

Table 3 Summary of self-reported symptoms/diseases among GWV by GWS status (ordered by frequency of reported ill health categories among GWS)

From: Self-reported ill health in male UK Gulf War veterans: a retrospective cohort study

Self-reported symptom

Frequency (%)

Adjusted2 odds ratio (95% CI)

 

GWS1

(n = 1,296)

unsure-GWS1

(n = 9,443)

non-GWS1

(n= 12,364)

GWS vs non-GWS

unsure GWS vs. non-GWS

All reporting ≥ 1 new symptom /disease since 1990

1,260 (97.2)

7,929 (84.0)

4,830 (39.1)

48.2 (34.5–67.4)***

8.0 (7.5–8.6)***

Mental and behavioural disorders

775 (59.8)

3,076 (32.6)

793 (6.4)

18.3 (15.9–21.0)***

6.6 (6.0–7.1)***

   Memory loss / lack of concentration

295 (22.8)

1,249 (13.2)

274 (2.2)

12.1 (10.0–14.7)***

6.6 (5.7–7.5)***

   Mood swings / aggression / irritability

327 (25.2)

1,147 (12.2)

214 (1.7)

16.1 (13.2–19.7)***

6.9 (5.9–8.0)***

   Anxiety / stress / sleep disturbance

220 (17.0)

769 (8.1)

213 (1.7)

10.8 (8.7–13.5)***

4.7 (4.1–5.6)***

   Depression

245 (18.9)

613 (6.5)

137 (1.1)

16.1 (12.7–20.4)***

5.5 (4.5–6.6)***

   PTSD and associated symptoms (mentioned specifically)

91 (7.0)

116 (1.2)

21 (0.2)

34.9 (20.8–58.7)***

6.4 (4.0–10.5)***

   Sexual dysfunction / lack of sex drive

42 (3.2)

123 (1.3)

27 (0.2)

13.1 (7.7–22.3)***

6.4 (4.2–9.9)***

   Other psychiatric / psychological disorders NOS3

93 (7.2)

237 (2.5)

47 (0.4)

14.7 (10.0–21.7)***

5.7 (4.1–7.9)***

Musculo-skeletal & connective tissue disorders

500 (38.6)

2,118 (22.4)

1,156 (9.4)

5.3 (4.6–6.1)***

2.6 (2.4–2.9)***

   Skeletal & other muscular symptoms

441 (34.0)

1,944 (20.6)

1,107 (9.0)

4.5 (3.9–5.2)***

2.5 (2.3–2.7)***

   Muscular pain / weakness (mentioned specifically)

122 (9.4)

265 (2.8)

68 (0.6)

16.2 (11.7–22.5)***

5.1 (3.9–6.7)***

Fatigue

462 (35.7)

1,742 (18.5)

397 (3.2)

15.4 (13.1–18.2)***

6.9 (6.1–7.7)***

   General fatigue

405 (31.3)

1,707 (18.1)

389 (3.2)

13.1 (11.1–15.5)***

6.8 (6.1–7.7)***

   Chronic fatigue syndrome / ME (mentioned specifically)

57 (4.4)

35 (0.4)

8 (0.1)

65.3 (29.4–145.1)***

6.1 (2.8–13.5)***

Other symptoms NOS 3

407 (31.4)

1,720 (18.2)

908 (7.3)

5.4 (4.7–6.3)***

2.8 (2.6–3.1)***

Nervous system disorders

373 (28.8)

1,284 (13.6)

415 (3.4)

10.0 (8.4–11.8)***

4.1 (3.6–4.6)***

   Headaches

266 (20.5)

958 (10.2)

308 (2.5)

8.7 (7.2–10.6)***

3.9 (3.4–4.5)***

   Numbness / tingling / dizziness

101 (7.8)

270 (2.9)

82 (0.7)

9.4 (6.8–12.9)***

4.0 (3.1–5.2)***

   Epilepsy

12 (0.9)

30 (0.3)

9 (0.1)

13.0 (5.0–34.1)***

3.5 (1.6–7.5)**

   Other neurological and neuromuscular problems NOS3

61 (4.7)

114 (1.2)

36 (0.3)

14.3 (9.1–22.5)***

4.2 (2.8–6.2)***

Skin allergies

242 (18.7)

994 (10.5)

531 (4.3)

4.9 (4.1–5.9)***

2.5 (2.3–2.8)***

Digestive, stomach & intestinal disorders

194 (15.0)

813 (8.6)

355 (2.9)

5.5 (4.5–6.7)***

3.2 (2.8–3.7)***

Respiratory disorders

194 (15.0)

860 (9.1)

400 (3.2)

5.1 (4.2–6.2)***

3.0 (2.6–3.4)***

   Asthma

71 (5.5)

342 (3.6)

188 (1.5)

3.8 (2.8–5.1)***

2.5 (2.1–3.0)***

   Respiratory problems NOS3

128 (9.9)

540 (5.7)

222 (1.8)

5.6 (4.4–7.2)***

3.2 (2.7–3.8)***

Infection

164 (12.7)

1,102 (11.7)

609 (4.9)

2.9 (2.4–3.5)***

2.6 (2.4–2.9)***

   Chronic / frequent infection

122 (9.4)

842 (8.9)

372 (3.0)

3.5 (2.8–4.4)***

3.3 (2.9–3.7)***

   Single episodes of acute infection

55 (4.2)

319 (3.4)

253 (2.1)

2.2 (1.6–3.0)***

1.8 (1.5–2.1)***

Endocrine, nutritional and metabolic disorders

116 (9.0)

366 (3.9)

134 (1.1)

7.4 (5.6–9.8)***

3.4 (2.8–4.2)***

   Hormonal imbalance / problems

14 (1.1)

36 (0.4)

20 (0.2)

7.0 (3.3–14.8)***

2.4 (1.4–4.2)***

   Diabetes

8 (0.6)

29 (0.3)

20 (0.2)

3.3 (1.4–7.9)***

2.0 (1.1–3.6)*

   Weight gain / loss

95 (7.3)

306 (3.2)

95 (0.8)

8.0 (5.8–10.9)***

3.9 (3.1–4.9)***

Deterioration in general health

92 (7.1)

494 (5.2)

256 (2.1)

3.2 (2.5–4.2)***

2.5 (2.1–2.9)***

   General deterioration of eyesight / hearing

53 (4.1)

310 (3.3)

212 (1.7)

2.2 (1.6–3.0)***

1.9 (1.5–2.2)***

   General decline in fitness / health

41 (3.2)

191 (2.0)

45 (0.4)

8.3 (5.1–13.5)***

5.7 (4.1–8.0)***

Cardiovascular disorders

90 (6.9)

344 (3.6)

237 (1.9)

3.8 (2.9–5.0)***

2.1 (1.8–2.5)***

Genito-urinary system disorders

77 (5.9)

238 (2.5)

143 (1.2)

5.3 (3.9–7.2)***

2.3 (1.8–2.8)***

   Genital system & bladder problems4

46 (3.6)

150 (1.6)

79 (0.6)

6.1 (4.0–9.2)***

2.7 (2.0–3.6)***

   Kidney disease / symptoms

35 (2.7)

101 (1.1)

68 (0.6)

4.4 (2.8–6.9)***

1.9 (1.4–2.6)***

Night sweats / excessive sweating / "fevers"

77 (5.9)

185 (2.0)

49 (0.4)

13.7 (9.2–20.2)***

4.7 (3.4–6.5)***

Chest pains / tightness (not elsewhere classified)

56 (4.3)

253 (2.7)

87 (0.7)

5.5 (3.8–7.9)***

3.3 (2.6–4.3)***

Auto-immune disease

37 (2.9)

136 (1.4)

64 (0.5)

5.2 (3.3–8.1)***

2.8 (2.1–3.8)***

Allergies other than skin

31 (2.4)

197 (2.1)

136 (1.1)

2.7 (1.8–4.1)***

2.2 (1.7–2.8)***

Cancer 5

19 (1.5)

61 (0.7)

42 (0.3)

5.1 (2.8–9.2)***

2.3 (1.5–3.4)***

Accidental injury

14 (1.1)

128 (1.4)

146 (1.2)

0.9 (0.5–1.5)

1.1 (0.8–1.4)

  1. 1Subject can appear in the table as many times as they reported different symptoms. More than one symptom within a group in the same subject counted once only. Number of symptoms in sub-groups may not add up to group total if more than one symptom was recorded within the group for the same subject. 2Adjusted for age at survey, service and rank at time of Gulf war, serving status at time of survey, alcohol consumption and smoking. 3Not Otherwise Specified (NOS) 4Category includes those reporting 'burning semen' GWS 6 (0.5%); unsure-GWS 5 (0.1%); non-GWS 2 (0.0%) 5Includes all reported malignant neoplasms, plus all reported brain tumours, benign or malignant. * 0.01 < p < 0.05 ** 0.001 < p < 0.01 *** p < 0.001